This compound is also reported to reduce steatosis and modify hepatic fatty acid profile stimulating carnitine-palmitoyltransferase-1 (CPT1)-mediated FAO, stimulating microsomal triglyceride transfer protein (MTP)-mediated very-low-density lipoprotein (VLDL) export and reducing lipid uptake by CD36 [39]. The gene discussed is MTTP; the disease is steatosis.